Publications by Dr Kevin Windebank - ePrints

Browsing publications by Dr Kevin Windebank.

Newcastle Authors	Title	Year
Dr Simon Bomken Dr Nicholas Bown Dr Peter Carey Dr Katrina Wood Dr Kevin Windebank et al.	Cutaneous B-Lymphoblastic Lymphoma With IL3/IgH Translocation Presenting With Hypereosinophilia and Acute Endocarditis	2015
Dr Simon Bomken Dr Kevin Windebank Professor Roderick Skinner	Salvage of multiply relapsed Burkitt's non-Hodgkin lymphoma by matched-unrelated donor haematopoietic stem cell transplantation	2012
Dr Naomi McGovern Dr Venetia Bigley Professor Muzlifah Haniffa Dr Xiao Wang Dr Rachel Dickinson et al.	Human Langerin plus dendritic cells are independent of epithelial Langerhans cells; a novel perspective on Langerhans cell histiocytosis	2011
Professor Mary Slatter Dr Brian Angus Dr Kevin Windebank Professor Sophie Hambleton Dr Mario Abinun et al.	Polymorphous lymphoproliferative disorder with Hodgkin-like features in common gamma-chain-deficient severe combined immunodeficiency	2011
Dr Jane Salotti Professor Mark Pearce Professor Louise Parker Dr Kevin Windebank	Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland	2009
Dr Kevin Windebank	Langerhans Cell Histiocytosis	2009
Professor Matthew Collin Dr Venetia Bigley Professor Muzlifah Haniffa Dr Kevin Windebank	Langerin Plus Dermal Dendritic Cells: Closer to Langerhans Cell Histiocytosis than Langerhans Cells?	2009
Dr Kevin Windebank Dr Brian Angus Dr Mario Abinun Dr Terence Flood Professor Andrew Cant et al.	Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency	2009
Dr Kevin Windebank Dr Bridget Wilkins	Post Cardiac Transplantation Lymphoproliferative Disorder Presenting as t(8;14) Burkitt Leukaemia/Lymphoma Treated With Low Intensity Chemotherapy and Rituximab	2009
Richard Feltbower Dr Richard McNally Professor Stephen Proctor Professor Roderick Skinner Professor Hermann Josef Vormoor et al.	The epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990-2002	2009
Dr Kevin Windebank	Advances in the management of histiocytic disorders	2008
Dr Kevin Windebank	Do as I say or die: Compliance in adolescents with cancer	2008
Dr Kevin Windebank Dr Brian Angus Dr Petra Dildey Dr Mario Abinun Dr Terence Flood et al.	Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency	2008
Dr Kevin Windebank	Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry	2008
Dr Jane Salotti Dr Kevin Windebank	An epidemiological survey of children with Langerhans Cell Histiocytosis in the UK and Eire, 2003-2006	2007
Richard Feltbower Dr Richard McNally Dr Kevin Windebank Professor Roderick Skinner	Epidemiology of haematological cancers in children and young adults aged 0-24 years in the north of England	2007
Dr Jane Salotti Dr Kevin Windebank	Langerhans Cell Histiocytosis (LCH) in children in the UK and Eire: An epidemiological survey	2007
Dr Penelope Taylor Dr Kevin Windebank Dr Helen Lucraft Dr Katrina Wood Dr Brian Angus et al.	Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents	2007
Dr Jane Salotti Dr Kevin Windebank	Langerhans Cell Histiocytosis	2006
Dr Jane Salotti Dr Kevin Windebank	Langerhans Cell Histiocytosis (LCH) In Children in the UK And Eire: Findings from a 2-year Epidemiological Survey	2006
Dr Ibrahim Ibrahim Dr Ee Lim Dr Salman Razvi Professor Simon Pearce Dr Stuart Bennett et al.	Langerhans cell histiocytosis: management dilemma for the adult endocrinologist	2006
Dr Kevin Windebank	A Comparison of Self-Reported Satisfaction Between Adolescents Treated in a "Teenage" Unit With Those Treated in Adult or Paediatric Units	2005
Professor Mark Pearce Professor Louise Parker Dr Kevin Windebank Simon Cotterill Emeritus Professor Alan Craft et al.	Cancer in adolescents and young adults aged 15-24 years: A report from the North of England Young Person's Malignant Disease Registry, UK	2005
Dr Katrina Wood Dr Kevin Windebank	Follicular dendritic cell tumour in a 9-year-old child	2005
Dr Kevin Windebank	Hodgkin's Disease and Adolescents	2005
Dr Kevin Windebank	Hodgkin's disease and adolescents: the lost tribe?	2005
Dr Kevin Windebank Dr Aileen Taylor	Juvenile xanthogranuloma associated with contralateral lymphadenopathy	2005
Dr Jane Salotti Dr Kevin Windebank	Population-Based Survey of Langerhans Cell Histiocytosis in Children in the United Kingdom and Eire: A Preliminary Report	2005
Professor Roderick Skinner Dr Kevin Windebank Dr Michael Reid	Demographic study of leukaemia presenting within the first 3 months of life in the Northern Health Region of England	2004
Andrew Barrett Dr Kevin Windebank	Factors influencing early failure of central venous catheters in children with cancer	2004
Dr Kevin Windebank	Starting an adolescent cancer unit: Why does it take so long?	2004
Professor Stephen Proctor Professor Graham Jackson Dr Anne Lennard Dr Brian Angus Dr Katrina Wood et al.	Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)	2003
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman Emeritus Professor Alan Craft Dr Juliet Hale Dr Jennifer Kernahan et al.	The United Kingdom Childhood Cancer Study: objectives, materials and methods	2000
Professor Deborah Tweddle Dr Kevin Windebank	Cyclosporin neurotoxicity after chemotherapy: Reply	1999
Professor Deborah Tweddle Dr Kevin Windebank Andrew Barrett	Central venous catheter use in UKCCSG oncology centres	1997
Dr Kevin Windebank Dr Michael Lowry Professor Andrew Pearson	Successful treatment of non-familial haemophagocytic lymphohistiocytosis with interferon and gammaglobulin	1996
Dr Stephen Pedler Emeritus Professor Alan Craft Dr Jennifer Kernahan Dr Kevin Windebank Professor Andrew Pearson et al.	Changing causes if septicemia in paediatric oncology patients: effect of imipenem use	1994
Dr Chris Redfern Dr Kevin Windebank	In vivo cytokine production during therapy for childhood leukemia	1994